BRIEF published on 08/06/2026 at 08:05, 1 month 17 days ago Pentixapharm publie ses résultats du deuxième trimestre et du premier semestre 2026 et fait progresser son programme de phase 3. Résultats Financiers Procédure Accélérée De La FDA Pentixapharm Pipeline En Oncologie Phase 3 PANDA
BRIEF published on 08/06/2026 at 08:05, 1 month 17 days ago Pentixapharm Reports Q2 and H1 2026 Results and Advances Phase 3 Program Financial Results Oncology Pipeline FDA Fast Track Pentixapharm Phase 3 PANDA
PRESS RELEASE published on 08/06/2026 at 08:00, 1 month 17 days ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program Pentixapharm Holding AG reports financial results for second quarter and first half of 2026, advancing Phase 3 Panda Program in oncology and cardiovascular sectors Financial Results Oncology Phase 3 Pentixapharm PANDA Program
BRIEF published on 07/31/2026 at 09:05, 1 month 23 days ago Pentixapharm Holding AG Advances with PentixaFor in Phase 3 Capital Raise Phase 3 PentixaFor Radiopharma PANDA Study
BRIEF published on 07/31/2026 at 09:05, 1 month 23 days ago Pentixapharm Holding AG fait progresser le PentixaFor en phase 3 Phase 3 Levée De Capitaux PentixaPour Radiopharma Étude PANDA
PRESS RELEASE published on 07/31/2026 at 09:00, 1 month 23 days ago Original-Research: Pentixapharm Holding AG (von NuWays AG): BUY Research update: Pentixapharm Holding AG positioned for Phase 3 with strong financing secured for PentixaFor diagnostic agent. Potential commercial partnering in 2027. Target price EUR 7.20 Financing Phase 3 Pentixapharm Commercial Partnering Diagnostic Agent
BRIEF published on 07/27/2026 at 20:55, 1 month 27 days ago Pentixapharm Raises EUR 20.4 Million Through Capital Increase Capital Increase FDA Fast Track Pentixapharm [68Ga]Ga-PentixaFor PANDA Phase 3
BRIEF published on 07/27/2026 at 20:55, 1 month 27 days ago Pentixapharm lève 20,4 millions d'euros par augmentation de capital Augmentation De Capital Procédure Accélérée De La FDA Pentixapharm [68Ga]Ga-PentixaPour PANDA Phase 3
PRESS RELEASE published on 07/27/2026 at 20:50, 1 month 27 days ago Pentixapharm Completes Capital Increase – New Shares Placed in Full Pentixapharm completes capital increase, raising EUR 20.4 million for PANDA Phase 3 activities and U.S. expansion after FDA milestones Capital Increase U.S. Expansion Pentixapharm PANDA Phase 3 FDA Milestones
BRIEF published on 07/27/2026 at 20:45, 1 month 27 days ago Pentixapharm lève 20,4 millions d'euros grâce à une offre sursouscrite Augmentation De Capital Développement Clinique Sursouscription Expansion Américaine Plateforme Théranostique
Published on 09/23/2026 at 22:00, 8 hours 56 minutes ago Petrolympic Adopts Semi-Annual Financial Reporting
Published on 09/23/2026 at 18:25, 12 hours 31 minutes ago Boba Mint Holdings Ltd. Reports Strong Early Subscription Adoption Following Soft Launch of Amino Pro
Published on 09/23/2026 at 15:42, 15 hours 14 minutes ago Global Atomic Announces C$50 Million Public Offering of Units
Published on 09/23/2026 at 14:31, 16 hours 25 minutes ago First Breach Completes First Untethered Flight of Proprietary Drone Prototype, Advancing American-Made Unmanned Systems Program
Published on 09/23/2026 at 14:30, 16 hours 26 minutes ago Phase II Clinical Trial of NV-387 as a Treatment for Monkeypox (MPox) Has Begun in DRC, Announces NanoViricides
Published on 09/24/2026 at 06:30, 26 minutes ago Forward-looking succession planning at the helm of V-ZUG
Published on 09/24/2026 at 05:55, 1 hour ago Donghai, China, Brings Crystal and Handcrafted Press-On Nails to Milan Fashion Week
Published on 09/24/2026 at 05:08, 1 hour 47 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Appendix 3G and 3H
Published on 09/24/2026 at 03:24, 3 hours 31 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: 2026 Notice of Annual General Meeting
Published on 09/23/2026 at 23:00, 7 hours 56 minutes ago Correction d’un communiqué du 23.09.2026 18:00 CET/CEST - MHM CORPORATE ANNONCE LE SUCCÈS DE SON AUGMENTATION DE CAPITAL AVEC MAINTIEN DU DROIT PREFERENTIEL DE SOUSCRIPTION AINSI QU’UN REMBOURSEMENT PARTIEL D’OBLIGATIONS REMBOURSABLES EN ACTIONS
Published on 09/23/2026 at 19:46, 11 hours 9 minutes ago SFPI GROUP: publication des résultats semestriels 2026
Published on 09/23/2026 at 19:14, 11 hours 41 minutes ago Robust performance from Investments and continued execution of the strategy
Published on 09/23/2026 at 19:14, 11 hours 41 minutes ago Performance robuste des Investissements, poursuite du déploiement de la stratégie
